QIAGEN(QGEN)
Search documents
QIAGEN(QGEN) - 2023 Q2 - Earnings Call Presentation
2023-08-09 16:43
Regulation G: QIAGEN reports adjusted results, as well as results on a constant exchange rate (CER) basis, and other non-U.S. GAAP figures (generally accepted accounting principles), to provide additional insight on performance. In this presentation, adjusted results include adjusted net sales, adjusted gross income, adjusted net income, adjusted gross profit, adjusted operating expenses, adjusted operating income, adjusted operating margin, adjusted net income before taxes, adjusted income tax, adjusted ta ...
QIAGEN(QGEN) - 2023 Q1 - Earnings Call Transcript
2023-05-04 19:17
Company Participants Today, weÂ'll first have some remarks from Thierry and Roland and then move into the Q&A session. Before we begin, let me briefly cover our Safe Harbor statement. This call discussion and responses to your questions reflect the views of management as of today May 4, 2023. We will be making statements and providing responses to your questions that state intentions, beliefs, expectations or predictions of the future. Operator Thank you, John, and a very warm welcome to all of you and obvi ...
QIAGEN(QGEN) - 2023 Q1 - Earnings Call Presentation
2023-05-04 14:48
Solid results driven by 12% CER net sales growth in non-COVID product groups Regulation G: QIAGEN reports adjusted results, as well as results on a constant exchange rate (CER) basis, and other non-U.S. GAAP figures (generally accepted accounting principles), to provide additional insight on performance. In this presentation, adjusted results include adjusted net sales, adjusted gross income, adjusted net income, adjusted gross profit, adjusted operating expenses, adjusted operating income, adjusted operati ...
Qiagen (QGEN) Investor Presentation - Slideshow
2023-03-24 13:31
First quarter 2023 Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks ...
QIAGEN(QGEN) - 2022 Q4 - Annual Report
2023-03-12 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to or ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI ...
QIAGEN(QGEN) - 2022 Q4 - Earnings Call Transcript
2023-02-08 19:00
Qiagen N.V. (NYSE:QGEN) Q4 2022 Earnings Conference Call February 8, 2023 9:00 AM ET Company Participants John Gilardi - Vice President, Head of Corporate Communications & Investor Relations Thierry Bernard - Chief Executive Officer Roland Sackers - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Aisyah Noor - Morgan Stanley Odysseas Manesiotis - Berenberg Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Andrew Brackmann - William Blair Falko Friedrichs - Deutsche Ba ...
QIAGEN(QGEN) - 2022 Q4 - Earnings Call Presentation
2023-02-08 15:13
Forward looking and intended use statements Regulation G: QIAGEN reports adjusted results, as well as results on a constant exchange rate (CER) basis, and other non-U.S. GAAP figures (generally accepted accounting principles), to provide additional insight on performance. In this presentation, adjusted results include adjusted net sales, adjusted gross income, adjusted net income, adjusted gross profit, adjusted operating expenses, adjusted operating income, adjusted operating margin, adjusted net income be ...
QIAGEN(QGEN) - 2022 Q3 - Earnings Call Transcript
2022-11-08 21:38
Qiagen N.V. (NYSE:QGEN) Q3 2022 Results Conference Call November 8, 2022 9:00 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - CEO Roland Sackers - CFO Conference Call Participants Odysseas Manesiotis - Berenberg Casey Woodring - JPMorgan Derik De Bruin - Bank of America Falko Friedrichs - Deutsche Bank Hugo Solvet - BNP Paribas Ed Ridley-Day - Redburn Operator Ladies and gentlemen, thank you for standing by. I am Perry, your PGI call operator. Welcome, and thank ...
Qiagen (QGEN) Presents at the Morgan Stanley 20th Annual Global Healthcare Conference - Slideshow
2022-09-15 17:34
Making improvements in life possible Investor resource book Third quarter 2022 Sample to Insight Forward looking and intended use statements Safe Harbor Statement: This presentation contains both historical and forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be forward looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. These s ...
QIAGEN(QGEN) - 2022 Q2 - Earnings Call Transcript
2022-07-29 04:43
Qiagen NV (NYSE:QGEN) Q2 2022 Earnings Conference Call July 28, 2022 9:30 AM ET Company Participants John Gilardi - VP, Corporate Communications & IR Thierry Bernard - CEO Roland Sacker - CFO Conference Call Participants Daniel Wendorff - ODDO BHF Patrick Donnelly - Citigroup Daniel Brennan - Cowen and Company Falko Friedrichs - Deutsche Bank Casey Woodring - JPMorgan Chase & Co. Matthew Sykes - Goldman Sachs Group Hugo Solvet - BNP Paribas Exane Operator Ladies and gentlemen, thank you for standing by. I a ...